Company: ZLAB
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038548
Chunk: 31

Company: Zai Lab Ltd
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 1
Chunk 31
---
 respectively)7 7 Additional paid-in capital3,308,491 3,264,295 Accumulated deficit(2,542,248)(2,453,083)Accumulated other comprehensive income46,348 50,515 Treasury Stock (at cost, 4,920,020 and 4,912,200 shares as of June 30, 2025 and December 31, 2024, respectively)(20,863)(20,836)Total shareholders’ equity791,735 840,898 Total liabilities and shareholders’ equity1,164,101 1,185,753 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

2

Zai Lab Limited 

Unaudited Condensed Consolidated Statements of Operations

(in thousands of $, except for number of shares and per share data) 

Three Months Ended June 30,Six Months Ended June 30,Notes2025202420252024RevenuesProduct revenue, net7109,085 100,106 214,735 187,255 Collaboration revenue7892 398 1,729 398 Total revenues109,977 100,504 216,464 187,653 ExpensesCost of product revenue(43,003)(35,148)(81,455)(68,767)Cost of collaboration revenue(217)(85)(412)(85)Research and development(50,614)(61,625)(111,343)(116,270)Selling, general, and administrative(71,038)(79,710)(134,460)(148,904)Loss from operations(54,895)(76,064)(111,206)(146,373)Interest income8,843 9,330 17,449 18,988 Interest expenses(1,262)(492)(2,449)(605)Foreign currency gains (losses)2,837 (4,108)3,488 (6,176)Other income (expense), net153,750 (8,943)3,553 418 Loss before income tax (40,727)(80,277)(89,165)(133,748)Income tax expense8— — — — Net loss(40,727)(80,277)(89,165)(133,748)Loss per share - basic and diluted9(0.04)(0.08)(0.08